Stay updated on Adjuvant Nivo/Ipi for Melanoma Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivo/Ipi for Melanoma Clinical Trial page.

Latest updates to the Adjuvant Nivo/Ipi for Melanoma Clinical Trial page
- Check3 days agoChange DetectedFooter revision changed from v3.2.0 to v3.3.2, a minor update that does not affect study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedRemoved the government funding status notice from the page; this is an administrative disclaimer that does not affect study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check18 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics as related topics on the Study Details page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoChange DetectedAdministrative updates are present, including a new last update date (2025-04-30) and QC verification, with no changes to study design, eligibility criteria, locations, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check39 days agoChange Detected- Added MedlinePlus Genetics topic: Melanoma. This expands the page's core content with genetics-related information about melanoma.SummaryDifference0.2%

- Check54 days agoChange Detected- Added a government funding notice and current operating status guidance, and updated the revision to v3.2.0. - Removed the MedlinePlus Genetics topic page on Melanoma and the older v3.1.0 revision.SummaryDifference4%

Stay in the know with updates to Adjuvant Nivo/Ipi for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivo/Ipi for Melanoma Clinical Trial page.